United States of America based
Auransa Inc. is an AI-driven pharmaceutical startup focusing on developing precise medicines for cancer, aging-related diseases and other disorders. We are a group of veteran drug developers, data scientists, biologists, chemists, and more, who share the common purpose of developing treatments for serious human diseases in order to save lives and relieve suffering.
Auransa’s innovative approach to developing precise medicine for patients is based on two core proprietary technologies developed over the past four years.
SMarTR™ Engine is an artificial intelligence (AI)-driven platform for discovering patient subpopulations, novel targets, unique mechanisms of action and precise therapies.
CTSeek™ Liquid Biopsy is a companion liquid biopsy technology that will ensure we are identifying the appropriate patients for our clinical trials and enable us to monitor their responses to our treatments.
TechnologiesAI Companies (Drug Discovery)
CTSeek™ Liquid Biopsy
No pipelines published yet
No services posted yet